Premium
Squamous cell carcinomas in situ arising in seborrheic keratoses: an association with concomitant immunosuppression?
Author(s) -
Boyd Alan S.,
Su Pei F.,
Shyr Yu,
Tang Yi W.
Publication year - 2014
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/ijd.12086
Subject(s) - medicine , immunosuppression , concomitant , dermatology , biopsy , seborrheic keratosis , basal cell , pathology
Background Seborrheic keratoses ( SK ) are the most common cutaneous neoplasm in humans. Given their numbers, a squamous cell carcinoma in situ ( SCCIS ) arising from an SK would not be unexpected, although this occurrence has not been widely reported. Objective This study compares the immune status of patients with a SCCIS arising contiguously from SK ( SK / SCCIS ) and the number of daily medications taken by these patients. The biopsy tissue was evaluated for the presence of human papillomavirus DNA . Methods Over a 5‐year period at our institution, 13 cases of SK / SCCIS were diagnosed. For each case, age‐ and sex‐matched control patients with a histologically diagnosed unremarkable SK were randomly selected. The number of patients taking immunosuppressing medications was determined from each group and compared statistically. In addition, polymerase chain reaction analysis of the 13 SK / SCCIS biopsies was performed. Results Five of the 13 study patients took immunosuppressive medications compared to none of the 39 control patients ( P = 0.0005). None of the biopsies demonstrated the presence of human papillomavirus DNA by polymerase chain reaction. Conclusions Immunocompromised patients with SK s appear to carry a greater risk of these otherwise innocuous lesions developing an SCCIS , although given the small number of patients evaluated, further research into this possible association is warranted.